Israel Ruiz

Insider

First SEC filing: Dec. 7, 2018 · Latest: Dec. 7, 2018

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 5 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
June 27, 2019	MRNA	A	54,660	—	—	54,660 Direct	—	Acquired	(price as of 2026-08-21)
Dec. 11, 2018	MRNA	C	4,559	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-21)
Dec. 11, 2018	MRNA	C	4,559	—	—	4,559 Direct	—	Acquired	(price as of 2026-08-21)
July 5, 2016	FTV	A	4,340	—	—	4,340 Direct	—	Acquired	(price as of 2026-08-21)
July 5, 2016	FTV	A	1,450	—	—	1,450 Direct	—	Acquired	(price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
June 27, 2019	MRNA	Stock Option (Right to Buy)	Common Stock (54,660)	$14.34	June 27, 2029	54,660	Acquired
Dec. 11, 2018	MRNA	Series G Preferred Stock	Common Stock (4,559)	—	—	4,559	Disposed
July 5, 2016	FTV	Director Stock Option	Common Stock, par value $0.01 (4,340)	$48.60	July 5, 2026	4,340	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
Dec. 7, 2018	MRNA	Series G Preferred Stock→ Common Stock (4,559)	4,559	Direct
Dec. 7, 2018	MRNA	Stock Option (Right to Buy)→ Common Stock (42,201)	42,201	Direct
Dec. 7, 2018	MRNA	Stock Option (Right to Buy)→ Common Stock (40,307)	40,307	Direct